STOCK TITAN

Orthofix Medical Inc. - $OFIX STOCK NEWS

Welcome to our dedicated page for Orthofix Medical news (Ticker: $OFIX), a resource for investors and traders seeking the latest updates and insights on Orthofix Medical stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Orthofix Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Orthofix Medical's position in the market.

Rhea-AI Summary
Orthofix Medical Inc. announces full U.S. commercial launch of Galaxy Fixation Gemini system for treating fractures resulting from trauma in limbs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
-
News
Rhea-AI Summary
Orthofix Medical Inc. announces leadership changes and postpones investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.17%
Tags
management
-
Rhea-AI Summary
Orthofix Medical Inc. to present at Morgan Stanley Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
conferences
Rhea-AI Summary
Orthofix Medical announces full commercial launch of 7D FLASH Navigation System Percutaneous Module 2.0
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.23%
Tags
none
-
Rhea-AI Summary
Orthofix Medical Inc. will host an Investor Day at its headquarters on September 20, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
conferences
-
Rhea-AI Summary
Orthofix Medical Inc. reports Q2 2023 net sales of $187.0 million, a 58% increase YoY. Bone Growth Therapies sees 10% growth, with U.S. spinal implants, biologics, and enabling technologies up 7% YoY. Gross profit increased to $119.6 million, but gross margin decreased to 63.9%. Net loss of $(39.4) million compared to net income of $2.5 million in prior year period. Adjusted EBITDA of $9.9 million, or 5.3% of net sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.31%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Orthofix Medical Inc.

Nasdaq:OFIX

OFIX Rankings

OFIX Stock Data

549.43M
26.16M
3.45%
97.5%
10.25%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
LEWISVILLE

About OFIX

orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing